# Sandra Schoors

> Sandra Schoors is a Series B investor at VIVES Funds backing Medical and Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [VIVES Funds](https://shizune.co/investors/profile/vives-funds)
- Total investments: 2
- Last investment: May 2026
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/sandra-schoors-0884b1114/?originalSubdomain=be
- Website: https://www.vivesfund.com/en/equipe/sandra-schoors

Sandra Schoors is a Series B investor at VIVES Funds focused on Medical and Health Care. Sandra Schoors, partner at VIVES Partners.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 50% |
| Health Care | 1 | 50% |
| Therapeutics | 1 | 50% |
| Health Diagnostics | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Nuclidium | NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics. | $33.6M | Series B | May 28, 2026 |  |
| Nuclidium | NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics. | $131.8M | Series B | Jul 10, 2025 |  |

2 of 2 investments shown.

## Co-investors
- [Angelini Ventures](https://shizune.co/investors/profile/angelini-ventures) — VC Fund, 2 deals together
- [Bayern Kapital](https://shizune.co/investors/profile/bayern-kapital) — VC Fund, 2 deals together
- [DeepTech & Climate Fonds](https://shizune.co/investors/profile/deeptech-climate-fonds) — VC Fund, 2 deals together
- [Kurma Partners](https://shizune.co/investors/profile/kurma-life-science-partners) — VC Fund, 2 deals together
- [Neva SGR](https://shizune.co/investors/profile/neva-a608) — VC Fund, 2 deals together
- [NRW.BANK](https://shizune.co/investors/profile/nrw-bank) — VC Fund, 2 deals together

## About VIVES Funds

VC Fund · Wavre, Belgium

VIVES is a seed capital fund initiated by UCLouvain which invests in companies developing disruptive innovations with a positive societal impact.

2 contacts available at VIVES Funds.

| Name | Title | Profile |
| --- | --- | --- |
| Sandra Schoors | Partner | https://shizune.co/investors/profile/sandra-schoors |
| Yannick Vancoppenolle | Partner | https://shizune.co/investors/profile/yannick-vancoppenolle |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Sandra Schoors invest in?

Sandra Schoors invests primarily in Medical, Health Care and Therapeutics startups, most often at Series B stage. Most of the 2 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Sandra Schoors last invest?

The most recent investment recorded for Sandra Schoors closed in May 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co